Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT05794984 Completed - Telemedicine Clinical Trials

Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece

Start date: May 2, 2023
Phase:
Study type: Observational

The current study seeks to address questions regarding internet and social media usage as well as telemedicine concept and knowledge, by conducting targeted focus group discussions (FGDs) and administering cross-sectional questionnaires among PWID in Greece. Further parameters, such as perceptions for high-quality healthcare access, confidentiality, privacy, and security, will also be explored.

NCT ID: NCT05794438 Completed - Clinical trials for Addiction, Substance

Gamified Adaptive Approach Bias Modification on Individuals With Methamphetamine Use History

Start date: March 10, 2023
Phase: N/A
Study type: Interventional

A randomized controlled trial will be conducted to investigate whether a proposed algorithm that adjusts the congruency ratio based on the user's performance and difficulty can enhance the effectiveness of approach bias modification. Methamphetamine users will be recruited and randomized into an algorithm group, a standard group, and a control group.

NCT ID: NCT05737550 Completed - Drug Abuse Clinical Trials

An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD

Start date: March 10, 2023
Phase: N/A
Study type: Interventional

This will be a pre-market, explorative, early feasibility, pilot, controlled clinical investigation designed to collect initial clinical data for Previct Drugs.

NCT ID: NCT05731999 Completed - Drug Abuse Clinical Trials

A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

This is a pre-market, explorative, early feasibility, pilot, controlled clinical investigation designed to collect initial clinical data on the medical device Previct Drugs.

NCT ID: NCT05731102 Completed - Clinical trials for Substance Use Disorders

Diagnostic Survey of Mental and Substance Use Disorders Among Norwegian College and University Students

Start date: January 24, 2023
Phase:
Study type: Observational

The aims of this observational survey are to 1) collect data on the prevalence of mental and substance use disorders, and 2) investigate risk factors and consequences of mental and substance use disorder

NCT ID: NCT05700305 Completed - Chronic Disease Clinical Trials

Physical Rehabilitation Intervention With Protein Supplementation for People With Problematic Substance Use and Homelessness

Start date: October 10, 2022
Phase:
Study type: Observational

Background: People who are homeless are more likely to experience poor mental health and addiction as well as suffering from non-communicable diseases. There is evidence of frailty and accelerated physical ageing among people experiencing homelessness. Appropriate physical rehabilitation and nutritional supplementation strategies can stabilize or reverse frailty and general physical decline, but it is not known how this type of intervention would work in practice in this population. Aim: To evaluate the feasibility and preliminary efficacy of a physical rehabilitation drop in intervention with protein supplementation to target physical functioning and frailty in people with problematic substance use who are experiencing homelessness. Methods: The intervention will consist of a 12-week low threshold physical rehabilitation program with protein supplementation. Participants will be service users of the Advance Ballyfermot Project, a day services center for people who are homeless and have active addiction issues. Primary outcomes will be feasibility including numbers recruited, retention of participants and number of repeat visits. Any adverse events will be recorded. Secondary outcomes will be strength and muscular mass, physical performance and lower extremity physical function, pain, frailty and nutritional status.

NCT ID: NCT05684939 Completed - Pain Clinical Trials

Relation Between Substance Use and Pain, in Patients Suffering or Surviving From Cancer and Followed in France

CAPS
Start date: January 27, 2023
Phase:
Study type: Observational

Pain is one of the most prevalent symptoms during and after cancer. Pain can be the consequence of several situations (disease progression, surgery, and anticancer drugs). However, pain can frequently be associated with a substance use disorder (alcohol, tobacco, drugs, and illicit products such as cannabis). The relationship between substance use and pain is known to be complex and interdependent, i.e. pain can reinforce substance use and substance use can promote pain. However, few data in the literature are available on the use of psychoactive substances in relation to pain in the context of cancer (cancer patients and cancer survivors). Moreover, the scientific literature agrees on the fact that these elements are little studied and underestimated in the clinic. The investigators hypothesize that, in cancer patients or cancer survivors, the prevalence of the use of psychoactive substances would be higher in the presence of pain, and would be associated with its intensity and its impact on the quality Health-Related Living (HRQoL). The main objective of this study will be to compare, in an adult population of patients suffering from cancer or having had cancer, the prevalence of the consumption of psychoactive substances in painful patients compared to non-painful patients.

NCT ID: NCT05665582 Completed - Caregiver Burden Clinical Trials

Family Members Affected by Substance Use Disorder - a Follow-up Study

Start date: January 1, 2016
Phase:
Study type: Observational

The present study registration relates to a quantitative sub-study of a larger mixed method study, including also a qualitative sub-study. Together, these investigations will provide complementary insights. The quantitative study is a follow-up study of close relatives (> 16 years) of patients in treatment for substance use disorder (SUD) who participated in a group-based 4-day psychoeducational program.

NCT ID: NCT05660434 Completed - Clinical trials for Substance Use Disorders

Using Aromatherapy in Substance Use Disorder

Start date: September 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this clinical trial study is to see if Bergamot, an aroma therapy essential oil, has any effect on comfort, ease, and stress. Participants will be asked to use a bergamot aroma inhaler, which is a small tube about the size of a lipstick container, at least three times a day for one week. Comfort, ease, and stress will be measured with self-report survey at the beginning and at the end of the week. In addition, participants will be asked to complete a daily logbook to record use of the inhaler. The study lasts for one week (7 days). The aims of this study are to explore the effects of Bergamot essential oil on comfort, ease, and stress in adults in a SUD treatment program, and to evaluate the feasibility of this type of aroma therapy intervention.

NCT ID: NCT05650983 Completed - Executive Function Clinical Trials

Effect of Exercise on Cognitive Function and Mental Health in Heroin Addicts

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The goal of this [type of study: exercise intervention study] is to test in describe participant health conditions. The main questions it aims to answer are: - [Whether physical exercise improves executive function of male heroin addicts] - [Whether physical exercise improves negative thinking/affect psychological experience of male heroin addicts] Participants will be randomly selected for medium-intensity strength training (resistance exercise,n=30), 30 will be selected for 1-hour long balloon volleyball sessions (aerobic exercise) at 60-70% volume of oxygen uptake during peak exercise, weekly 5 times for 12 weeks; and 30 will be assigned to the no-exercise control group, Participants will perform Executive function tests and the Symptom Checklist-90 Revised questionnaire at pre and post intervention. Researchers will compare resistance exercise group,aerobic exercise group and no-exercise control group to see if effects of exercise on executive function and negative thinking/affect psychological experience of male heroin addicts.